Search / Trial NCT06227078

Effects of Kinesiotaping and Physiotherapy in Grade 2 Osteoarthritis Following Degenerative Meniscal Tears

Launched by GOPAL NAMBI · Jan 25, 2024

Trial Information

Current as of October 07, 2024

Completed

Keywords

Description

Degenerative meniscal tears represent a prevalent issue among football players and are frequently associated with an increased risk of developing knee osteoarthritis. This study seeks to explore the clinical and functional impacts of employing kinesiotaping and physiotherapy as interventions in grade 2 osteoarthritis resulting from degenerative meniscal tears in football players. Kinesiotaping is a therapeutic technique involving the application of specialized elastic tapes to targeted areas, aiming to support injured muscles and joints, enhance circulation, and alleviate pain. Physiothera...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Diagnosis of Knee Osteoarthritis:
  • Individuals with a confirmed diagnosis of knee osteoarthritis based on clinical and/or radiological assessments.
  • Mild to Moderate Knee OA:
  • Kinesiotaping may be more appropriate for individuals with mild to moderate knee OA rather than severe cases.
  • Presence of Pain and Discomfort:
  • Individuals experiencing pain, discomfort, or limitations in function related to knee osteoarthritis.
  • Functional Limitations:
  • Those with functional limitations in activities of daily living or reduced mobility due to knee OA.
  • No Contraindications:
  • Individuals without contraindications to kinesiotaping, such as skin allergies, infections, or open wounds in the application area.
  • Willingness to Participate:
  • Individuals who are willing to participate in and adhere to the kinesiotaping intervention.
  • Not Responsive to Other Conservative Treatments:
  • Those who have tried and not responded adequately to other conservative treatments for knee OA, such as exercise, physical therapy, or oral medications.
  • Absence of Serious Comorbidities:
  • Individuals without serious comorbidities or medical conditions that may contraindicate the use of kinesiotaping.
  • Individual Preferences:
  • Consideration of individual preferences and acceptance of kinesiotaping as part of the treatment plan.
  • Exclusion Criteria:
  • * 1. Skin Conditions:
  • * Active skin infections, allergies, or open wounds in the area where kinesiotape is to be applied.
  • * Skin conditions that may be aggravated or worsened by the adhesive in the tape. 2. Vascular Disorders:
  • * Conditions that affect blood circulation, such as peripheral vascular disease, deep vein thrombosis, or other vascular disorders, which may be worsened by the application of kinesiotape.
  • 3. Peripheral Neuropathy:
  • * Individuals with peripheral neuropathy or other nerve disorders, as kinesiotaping may affect sensation, and there is a risk of injury or discomfort.
  • 4. Cancer or Tumors:
  • * Active cancer or tumors in the region where kinesiotape is to be applied, as kinesiotaping could interfere with cancer treatment or exacerbate symptoms.
  • 5. Joint Instability:
  • * Individuals with severe joint instability, as kinesiotape may not provide sufficient support for highly unstable joints.
  • 6. Allergies to Tape Components:
  • * Known allergies to the materials or adhesive used in kinesiotape. 7. Circulatory Disorders:
  • * Severe circulatory disorders, which may be exacerbated by the pressure or tension applied by kinesiotape.

About Gopal Nambi

Gopal Nambi is a dedicated clinical trial sponsor specializing in advancing medical research through innovative study designs and rigorous methodologies. With a strong commitment to improving patient outcomes, Gopal Nambi collaborates with leading healthcare professionals and institutions to facilitate the development of cutting-edge therapies. The organization prioritizes ethical standards and regulatory compliance, ensuring that all trials are conducted with the utmost integrity and respect for participant safety. Through its strategic partnerships and focus on scientific excellence, Gopal Nambi aims to contribute significantly to the evolution of modern medicine and the enhancement of healthcare solutions.

Locations

Al Kharj, Riyad, Saudi Arabia

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0